Early stage prostate cancer is very common. However, current methods for diagnosis and treatment miss significant cancers in some men, and over-treat others with therapies that are expensive, lengthy, and have significant risks and morbidity. MRI is emerging as a promising method for revealing clinically significant prostate cancer, raising the provocative possibility of minimally invasive, focal, MR-guided therapy that would be more selective, safer, and quicker than current whole-gland radiotherapy and surgical procedures.
The aims of this project are to develop minimally invasive biopsy and treatment methods for prostate cancer: 1. Design, testing and final fabrication of a new system for real-time, interactive, trans-perineal minimally invasive access to the prostate while the patient is in a 3T MRI scanner, using MRI-compatible robotic technology for passive remote needle manipulation, embedded miniature fiber optics and MR-tracking to sense needle shape and tip position, and integration with real-time MR scanning for automated visualization. 2. Clinical Trial of MRI-guided Trans-perineal biopsy of prostate targets, compared with subsequent TRUS-guided standard systematic 12-core biopsies (the gold standard) in 12 men with abnormal PSA levels. 3. Development and in vivo testing of MRI-compatible needle tip micro-robotics to dramatically increase physician control, including needle tip force sensing and rendering, and photonic needle tip steering. 4. Investigation of 3T methods for guiding and monitoring cryosurgery, including ultra-short TE 3D MR thermal mapping in frozen tissue, and advanced diffusion and MT-weighted images of acute cryo-injury. When complete, these technologies will be poised for future clinical trials assessing the utility of minimally invasive MRI-guided focal cryosurgery for treating early stage prostate cancer
Achieving the aims of this project will provide a simple, powerful, intuitive, elegant method for biopsy and cryoablation of focal prostate targets, using MRI guidance, that is ready for clinical trials. Essential biopsy system components will have been tested in humans. Second generation robotic sensing and control mechanisms, and MRI imaging of tissue freezing effects will have been validated at 3T and tested in vivo.
|Ellenor, Christopher W; Stang, Pascal P; Etezadi-Amoli, Maryam et al. (2015) Offline impedance measurements for detection and mitigation of dangerous implant interactions: an RF safety prescreen. Magn Reson Med 73:1328-39|
|Etezadi-Amoli, Maryam; Stang, Pascal; Kerr, Adam et al. (2015) Interventional device visualization with toroidal transceiver and optically coupled current sensor for radiofrequency safety monitoring. Magn Reson Med 73:1315-27|
|Scott, Serena J; Salgaonkar, Vasant; Prakash, Punit et al. (2014) Interstitial ultrasound ablation of vertebral and paraspinal tumours: parametric and patient-specific simulations. Int J Hyperthermia 30:228-44|
|Vyas, Urvi; Kaye, Elena; Pauly, Kim Butts (2014) Transcranial phase aberration correction using beam simulations and MR-ARFI. Med Phys 41:032901|
|Bitton, Rachel R; Pauly, Kim R Butts (2014) MR-acoustic radiation force imaging (MR-ARFI) and susceptibility weighted imaging (SWI) to visualize calcifications in ex vivo swine brain. J Magn Reson Imaging 39:1294-300|
|Rube, Martin A; Holbrook, Andrew B; Cox, Benjamin F et al. (2014) Wireless MR tracking of interventional devices using phase-field dithering and projection reconstruction. Magn Reson Imaging 32:693-701|
|Prakash, Punit; Salgaonkar, Vasant A; Diederich, Chris J (2013) Modelling of endoluminal and interstitial ultrasound hyperthermia and thermal ablation: applications for device design, feedback control and treatment planning. Int J Hyperthermia 29:296-307|
|Rieke, Viola; Instrella, Ron; Rosenberg, Jarrett et al. (2013) Comparison of temperature processing methods for monitoring focused ultrasound ablation in the brain. J Magn Reson Imaging 38:1462-71|
|Sommer, Graham; Pauly, Kim Butts; Holbrook, Andrew et al. (2013) Applicators for magnetic resonance-guided ultrasonic ablation of benign prostatic hyperplasia. Invest Radiol 48:387-94|
|Sommer, Graham; Bouley, Donna; Gill, Harcharan et al. (2013) Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance. Can J Urol 20:6672-81|
Showing the most recent 10 out of 11 publications